Wolfgang Miesbach/LinkedIn
Feb 25, 2026, 12:36
Wolfgang Miesbach: Repurposing Metformin – From Sugar Control to Thrombus Control
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn:
”Repurposing Metformin: From Sugar Control to Thrombus Control
One of the many excellent posters at this year’s GTH 2026 meeting in Bonn was from the team in Düsseldorf, exploring an unexpected player in abdominal aortic aneurysm (AAA) therapy: the antidiabetic drug metformin.
Their work looks at how metformin modulates platelet activation and ex vivo thrombus formation in human whole blood – a fascinating angle, given the growing recognition that platelets and intraluminal thrombus are not just bystanders but active drivers of AAA progression:
- A ‘classic’ diabetes drug being repurposed to target vascular inflammation and thrombosis, in a disease area where truly effective pharmacological treatments are still lacking.
- Experimental data suggesting that metformin can inhibit platelet activation and arterial/venous thrombosis without prolonging bleeding time, by acting on mitochondrial pathways – hinting at a new, ‘metabolic’ form of antiplatelet therapy.
- Use of human samples and arterial‑shear thrombus assays keeps the model close to clinical reality and directly links cellular mechanisms to the thrombotic milieu observed in AAA.
- The concept that dampening platelet hyperreactivity might not only reduce thrombotic complications but also slow aneurysm expansion is particularly attractive and could complement ongoing clinical trials of metformin in AAA.”
Stay updated with Hemostasis Today.
-
Feb 25, 2026, 12:30Bethany Brown: There Is A Need for A Validated Replacement for The Discontinued 2,3-DPG Assay
-
Feb 25, 2026, 12:20Register for A Webinar on von Willebrand Disease in Ageing – EHC
-
Feb 25, 2026, 12:09Ellis Neufeld is Appointed as New Associate Editor of Blood
-
Feb 25, 2026, 12:02WFH Continues to Advance More Precise and Sustainable Care for People with Bleeding Disorders
-
Feb 25, 2026, 09:14Nominations are Open for 2027 Committee and Leadership Positions – ASH
-
Feb 25, 2026, 09:08Bastu Odoka: Closing the Gap on Anti-D Prophylaxis in Maternal Care
-
Feb 25, 2026, 08:53Eiman Alzaabi: Sharing Rare Observations and Challenging Assumptions in Transfusion Medicine
-
Feb 25, 2026, 08:40Matthew Flick։ A Great Gordon Research Conference on Plasminogen Activation and Extracellular Proteolysis
-
Feb 24, 2026, 16:18Salmaan Dalvi: Mapping Rare Diseases Across East and Central Africa